Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Akhilesh Mahajan; Jonathan Moore; Anup K Singh; Margarita Oks

doi:10.4187/respcare.10067

Editorialeditorial

Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Akhilesh Mahajan, Jonathan Moore, Anup K Singh and Margarita Oks

Respiratory Care May 2022, 67 (5) 629-630; DOI: https://doi.org/10.4187/respcare.10067

Akhilesh Mahajan

Department of Pulmonary and Critical Care Medicine mLenox Hill HospitalNorthwell Health SystemNew York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jonathan Moore

Department of Pulmonary and Critical Care Medicine mLenox Hill HospitalNorthwell Health SystemNew York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anup K Singh

Department of Pulmonary and Critical Care Medicine mLenox Hill HospitalNorthwell Health SystemNew York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: asingh21@northwell.edu

Margarita Oks

Department of Pulmonary and Critical Care Medicine mLenox Hill HospitalNorthwell Health SystemNew York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
References
PDF

You are using an old browser, click here to download PDF

PDF Container

PreviousNext

In this issue

Respiratory Care

Vol. 67, Issue 5

1 May 2022

Table of Contents
Table of Contents (PDF)
Cover (PDF)
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Message Subject (Your Name) has sent you a message from American Association for Respiratory Care

Message Body (Your Name) thought you would like to see the American Association for Respiratory Care web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Akhilesh Mahajan, Jonathan Moore, Anup K Singh, Margarita Oks

Respiratory Care May 2022, 67 (5) 629-630; DOI: 10.4187/respcare.10067

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Akhilesh Mahajan, Jonathan Moore, Anup K Singh, Margarita Oks

Respiratory Care May 2022, 67 (5) 629-630; DOI: 10.4187/respcare.10067

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
- Footnotes
- References
Info & Metrics
References
PDF

Main menu

User menu

Search

Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

In this issue

Citation Manager Formats

Related Articles

Cited By...

Info For

About Us

AARC

More